Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on August 31, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

ALBENDAZOLE TABLETS

Closed
SPE2DP-26-T-4792Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

Solicitation SPE2DP-26-T-4792, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a request for quotations for the procurement of 11 bottles of Albendazole Tablets, USP (NSN 6505016493422). Each bottle contains two 200 mg tablets and must be stored at a controlled room temperature between 20 and 25 degrees Celsius. The product is a Type I Code M item with a non-extendable shelf life of 24 months. Delivery is required within 20 days after order, with an original required delivery date of September 1, 2026. The shipment is FOB Destination, with both inspection and acceptance occurring at the destination point, specifically the Medical Logistics facility at Fort Bragg, North Carolina. The contract mandates strict adherence to commercial packaging and marking standards. All materials must be marked according to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must follow DLA Packaging Requirements for Procurement (RP001), and non-hazardous materials must comply with ASTM D3951. If the material is deemed hazardous per FED-STD-313, it must be packaged according to TQ requirement IP025 and labeled per the Hazard Communication Standard. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses, including the Buy American Act, the Berry Amendment, and safeguarding of covered defense information.

General Info

Procurement of 11 bottles of Albendazole 200mg tablets for delivery by September 2026.

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

BLD A5474 PRATT ST, FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

1

SPE2DP-26-T-4792 Request for Quotations

PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
ALBENDAZOLE TABLETS
ALBENDAZOLE TABLETS,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
200 MG 2 TABLETS PER BOTTLE
U/I BOTTLE
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
1 BT = 2 TT
. STORE AT CONTROLLED ROOM TEMPERATURE 20° TO 25°C (68° TO 77°F) [SEE
USP].
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information,
SPE2DP-26-T-4792
SECTION B
manufacturer name, manufacturer part number, and item description. .
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
GOLDEN STATE MEDICAL, INC 3JLW4 P/N NDC51407-0258-02 EDENBRIDGE PHARMACEUTICALS, LLC 5BXS8 P/N NDC42799-0110-02
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018093885 0001 BT 11.000
NSN/MATERIAL:6505016493422
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
SPE2DP-26-T-4792
SECTION B
PR: 7018093885 PRLI: 0001 CONT’D
FREIGHT SHIPPING ADDRESS:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
MARKFOR
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
M/F: (TCN) W50YF262390024
RDD: 253
PROJ: TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:09/01/2026
SPE2DP-26-T-4792 NSN/Part Number: 6505-01-649-3422 Quantity: 11 BT Purchase Request: 7018093885QTY: 11 Delivery: 20 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 423450
New
DIBBS
SODIUM CHLORIDE INJECT
Solicitation # SPE2DP-27-T-0167
Solicitation SPE2DP-27-T-0167 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Sodium Chloride Injection. The required product consists of 10 ML preservative-free, latex-free dispensing syringes, packaged in trays of 30 syringes per unit of issue. This FDA-regulated drug is classified as a Type I Code M item with a non-extendable shelf life of 24 months. The solicitation includes multiple contract line items for delivery to various locations, including Fort Bliss, Texas, and Fort Bragg, North Carolina, with a required delivery period of 20 days and an original required delivery date of October 27, 2026. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires commercial packaging per ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials. Palletization must comply with DLA packaging requirement RP001. Terms are FOB Destination, with inspection and acceptance also occurring at the destination. Offerors must submit quotes via the DIBBS system and are encouraged to provide quantity ranges. This acquisition is not a small business set-aside and falls under NAICS code 423450. Payment and invoicing are to be processed electronically through the Wide Area WorkFlow system.
Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

about 5 hours ago

DEADLINE

in 6 days
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS